Safety Information
Intended Use
The intended use of the Boston Scientific DBS System is to treat movement disorders by stimulating a specific brain target.
Clinical Benefit
The clinical benefit of the Boston Scientific DBS System is reduction of motor symptoms of the disease state (Parkinson's
disease, dystonia, tremor). Other benefits known to occur from motor symptom reductions are increased functionality and quality
of life. Patients often have decreased use of medications and therefore fewer side effects from medication.
Device Lifetime
The minimum lifetime of the implantable components is 5 years. However, the non-rechargeable IPG may have less than 5 years
of lifetime depending on the stimulation settings and conditions. See the "Non‑Rechargeable IPG Battery Information" section of
this manual for more information about the non-rechargeable IPG battery.
Information for Patients
92694767-14
9 of 255